Literature DB >> 15505069

Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial.

Susanne Binder1, Ilse Krebs, Ralf-Dieter Hilgers, Ali Abri, Ulrike Stolba, Adele Assadoulina, Lukas Kellner, Boris V Stanzel, Christian Jahn, Hans Feichtinger.   

Abstract

PURPOSE: To present the outcome of a consecutive series of patients who had foveal choroidal neovascularization (fCNV) in age-related macular degeneration (AMD) and were treated with subretinal surgery combined with simultaneous transplantation of autologous retinal pigment epithelial (RPE) cells.
METHODS: Patients with fCNV who were not eligible for laser or photodynamic therapy were included in the study. They underwent subretinal membrane excision with simultaneous transplantation of autologous RPE cells. Eyes with membrane excision alone served as the control. Tests included best corrected visual acuity for far and near with Early Treatment Diabetic Retinopathy Study (ETDRS) and Jaeger charts, multifocal (mf)ERG, central visual field analysis, optical coherence tomography (OCT), and angiography, before surgery, and 1 month and 3 months after treatment, and at 3-month intervals thereafter.
RESULTS: The results of final examinations of 53 eyes are presented. In 39 eyes, RPE transplantation was performed (group 1); 14 eyes had membrane excision alone (group 2). In group 1, visual acuity improved significantly, two or more lines in 21 (53.8%) patients; remained stable in 12 patients (30.8%); and decreased two or more lines in 6 patients (15.4%; P=0.0062). In group 2, the corresponding values were 21.1%, 57.8%, and 21.1% (P=0.5377 NS). Statistical analysis of results in the two groups showed a trend in favor of group 1 (P=0.9714). The difference in reading acuity was significant between the two groups (mean change in group 1: 1.85 +/- 0.42 vs. 0.43 +/- 0.47 in group 2; P=0.0001). mfERG response density changes were significantly different between groups 1 and 2 (P=0.0094). No significant decreases in central visual field defects were detected. OCT showed the postoperative median retinal thickness in the lesion area in group 1 to be higher (242.31 +/- 12.30 microm) than in group 2 (202.07 +/- 10.68 microm), showing a trend (P=0.0682).
CONCLUSIONS: Patients undergoing fCNV removal with autologous transplantation of RPE reached significantly better reading acuity and higher mfERG-response density than control subjects. The results provide evidence that autologous transplantation of RPE is a beneficial supplement to membrane excision alone in patients with fCNV in AMD and may be regarded as a reasonable treatment option.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505069     DOI: 10.1167/iovs.04-0118

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  54 in total

1.  Which treatment is best for which AMD patient?

Authors:  P Kroll; C H Meyer
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

2.  Epidermal growth factor: the driving force in initiation of RPE cell proliferation.

Authors:  Kerstin Steindl-Kuscher; Michael E Boulton; Paulina Haas; Astrid Dossenbach-Glaninger; Hans Feichtinger; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-15       Impact factor: 3.117

3.  Epidermal growth factor inhibits glycogen synthase kinase-3 (GSK-3) and beta-catenin transcription in cultured ARPE-19 cells.

Authors:  Walter Krugluger; Stefan Seidel; Kerstin Steindl; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-10       Impact factor: 3.117

4.  Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane.

Authors:  Janosch P Heller; Keith R Martin
Journal:  Transl Vis Sci Technol       Date:  2014-07-03       Impact factor: 3.283

Review 5.  Induced pluripotent stem cell therapies for geographic atrophy of age-related macular degeneration.

Authors:  Hongjun Du; Siok Lam Lim; Seanna Grob; Kang Zhang
Journal:  Semin Ophthalmol       Date:  2011-05       Impact factor: 1.975

6.  Performing subretinal injections in rodents to deliver retinal pigment epithelium cells in suspension.

Authors:  Peter D Westenskow; Toshihide Kurihara; Stephen Bravo; Daniel Feitelberg; Zack A Sedillo; Edith Aguilar; Martin Friedlander
Journal:  J Vis Exp       Date:  2015-01-23       Impact factor: 1.355

7.  Biobanking of Human Retinas: The Next Big Leap for Eye Banks?

Authors:  Zala Lužnik; Mohit Parekh; Marina Bertolin; Carlo Griffoni; Diego Ponzin; Stefano Ferrari
Journal:  Stem Cells Transl Med       Date:  2015-06-01       Impact factor: 6.940

8.  Transplantation of rat embryonic stem cell-derived retinal cells restores visual function in the Royal College of Surgeons rats.

Authors:  Hongxi Wu; Jia Li; Xinbang Mao; Guodong Li; Lin Xie; Zhipeng You
Journal:  Doc Ophthalmol       Date:  2018-08-03       Impact factor: 2.379

9.  Age-related macular degeneration: current treatments.

Authors:  Jean Pierre Hubschman; Shantan Reddy; Steven D Schwartz
Journal:  Clin Ophthalmol       Date:  2009-06-02

Review 10.  Eye development and retinogenesis.

Authors:  Whitney Heavner; Larysa Pevny
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-12-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.